Debut Plus

₹70

▼ -0.36 -0.51%

17 Jul 2026

BSE Listed

Concord Drugs Limited (538965)

Volume: 889Avg Vol 1W: 2,061Avg Vol 1M: 3,49252W Range:₹49₹92.52
BSE www.concorddrugs.in
Key Ratios
Checked just now
Market Cap₹92 Cr
Current Price₹70
Previous Close₹70.36
High / Low (52w)₹92.52 / ₹49
Volume889
Avg Vol (1W)2,061
Avg Vol (1M)3,492
Stock P/E87.5
Book Value₹36.82
Dividend Yield0%
ROE217.46%
ROA141.54%
Revenue (TTM)—
Revenue Growth—
Profit Margin134.6%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.8
P/B1.9
Debt / Equity0.54
50 DMA₹78.08
200 DMA₹77.4
Day change-0.51%
Price Chart
₹70▲ 12.81% · 1Y
₹90₹3665K
2025-07-17
2026-07-17

20-day avg volume: 3K shares

Pros
  • Healthy return on equity of 217.5%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 88.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹12 Cr₹12 Cr₹11 Cr₹10 Cr₹14 Cr₹10 Cr₹17 Cr₹38 Cr
EBITDA₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2022Mar 2023Mar 2024Mar 2025
Revenue₹59 Cr₹52 Cr₹45 Cr₹45 Cr
EBITDA₹4 Cr₹3 Cr₹2 Cr₹3 Cr
Net Profit₹2 Cr₹1 Cr₹0 Cr₹0 Cr
EPS1.821.060.470.34
Balance Sheet
MetricMar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹56 Cr₹58 Cr₹59 Cr₹65 Cr
Total Liabilities₹28 Cr₹27 Cr₹25 Cr₹31 Cr
Equity₹28 Cr₹32 Cr₹34 Cr₹34 Cr
Total Debt————
Cash Flow
MetricMar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹2 Cr₹1 Cr₹4 Cr
Investing₹-2 Cr₹-2 Cr₹-1 Cr₹-2 Cr
Financing₹2 Cr₹1 Cr₹0 Cr₹-1 Cr
Free Cash Flow₹-1 Cr₹1 Cr₹0 Cr₹2 Cr
Shareholding
Promoter 54.39% Institutions 0% Public 45.61%
Efficiency & Working Capital
ROCE5.1%
Interest Coverage1.3
Dividend Payout—
Debtor Days110 d
Inventory Days204 d
Payable Days61 d
Cash Conversion Cycle252 d
Working Capital Days314 d
Shareholding Details

As of 2026-03-31

Promoter54.4%
FII0%
DII0%
Institutions0%
Public45.6%
Promoter Pledge0%
No. of Shareholders4,464
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodOct 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Nov 2025Dec 2025Mar 2026
Promoters55.4%55.4%55.4%55.4%54.4%54.4%54.4%54.4%54.4%45.1%54.4%54.4%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public44.6%44.6%44.6%44.6%45.6%45.6%45.6%45.6%45.6%54.9%45.6%45.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3,9634,0324,7344,7555,0735,0735,2525,1894,7184,5974,5974,464
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Nagi Reddy SeelamShareholding of Promoter and Promoter Group28.6%28,60,536
Manojkumarreddy SeelamShareholding of Promoter and Promoter Group16.3%16,28,125
Seelam Koni ReddyShareholding of Promoter and Promoter Group9.5%9,50,543
Ganga Devi LoyaPublic Shareholding1.9%1,93,525
Rajender Kumar AgarwalPublic Shareholding1.5%1,48,854
S N Thulasi DeviPublic Shareholding1.2%1,21,200
K Ramesh ReddyPublic Shareholding1.1%1,04,600
Mohan ThodupunuriPublic Shareholding1%1,01,006
Rakesh KPublic Shareholding1%1,00,000
Sannuthi LokeshPublic Shareholding1%1,00,000
Ekta VijaywargiPublic Shareholding1%99,999
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Nagi Reddy Seelam00%2026-03-31
Seelam Koni Reddy00%2026-03-31
Manojkumarreddy Seelam00%2026-03-31
Mohan Thodupunuri00%2026-03-31
Rajender Kumar Agarwal00%2026-03-31
Ganga Devi Loya00%2026-03-31
Ekta Vijaywargi00%2026-03-31
S N Thulasi Devi00%2026-03-31
K Ramesh Reddy00%2026-03-31
Rakesh K00%2026-03-31
Sannuthi Lokesh00%2026-03-31
Nagi Reddy Seelam00%2025-12-31
Board of Directors
NameDesignationYear
S Nagi ReddyChairman / Executive Director / M D / Promoter2025
Koni ReddyED / WTD / CFO / Promoter2025
S. Manoj Kumar ReddyWTD & Executive Director2025
K Ramchandra ReddyIndependent Non Exe. Director2025
Summela KasuIndependent Non Exe. Director2025
S. Nagavenkata HareeshIndependent Non Exe. Director2025
Satyam Reddy GopidiIndependent Non Exe. Director2025
NamrathaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing₹28 Cr49.3%
Trading₹29 Cr50.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10111010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202521101014
2025080109
2025230005
Substantial Acquisitions (SAST)

9 disclosure(s)

Pref. Allotment20/11/2025 · 5,00,000
Pref. Allotment20/11/2025 · 5,00,000
Pref. Allotment20/11/2025 · 5,00,000
Pref. Allotment27/10/2023 · 3,42,266
Pref. Allotment27/10/2023 · 3,42,266
Pref. Allotment12/10/2023 · 3,42,264
Company Information
Incorporated1995
ChairmanS Nagi Reddy
AuditorPundarikashyam and Associates
Investor Email[email protected]
🌐 www.concorddrugs.in ↗

📍 Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Mercantile VenturesSonal MercantileAbhinav Leasing & FinanceGenus Paper & BoardsMinda CorporationMercury Laboratories LimitedWardwizard Innovations AnShree Securities Ltd.Talbros Engineering LimitedSAR Auto Products LimitedPurohit Construction LimitedJayatma Enterprises LimitedAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search